The Effervescent Tablet Market is being driven by Increasing adoption of effervescent tablets among aging population
The Effervescent Tablet Market is expected to grow at a CAGR of 8.36% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 4.80 billion. The young demographic segment has shown a trend of avoiding nutritious food, leading to an increased prevalence of nutrient deficiencies. To address this issue, the market for effervescent tablets, a type of nutraceutical product, has gained significant traction. These tablets, available in various formats, shapes, and flavors, offer a fun and convenient solution for meeting daily nutritional requirements. Vendors like Strava Healthcare Pvt. Ltd. cater to this demand by providing effervescent vitamin products in appealing shapes, such as bears, fruits, and flowers, and various flavors. This not only makes the supplementation process enjoyable for the young population but also ensures that they receive essential nutrients in a palatable and hassle-free manner. Moreover, there is a growing awareness among parents regarding the importance of providing their children with high-quality vitamin supplements, further fueling the demand for effervescent tablets.
Get more information on Effervescent Tablet Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
159 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 8.36% |
|
Market growth 2024-2028 |
USD 4.80 billion |
|
Market structure |
market_structure.ucfirst |
|
YoY growth 2023-2024(%) |
7.84 |
|
Key countries |
US, Germany, UK, India, and Japan |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The effervescent tablet market caters to various demographic groups, particularly those dealing with health issues related to vitamins and minerals deficiencies. Producers of effervescent tablets have identified significant market opportunities, as these tablets offer advantages over conventional solid dosage forms like capsules and tablets. The effervescent reaction, which involves the release of carbon dioxide upon contact with water, provides faster dissolution and improved bioavailability. However, the manufacturing process of effervescent tablets involves additional processing steps, such as tablet disintegration, mixing, granulation, and tablet compression. These steps increase production costs and require specialized equipment, raw ingredients, personnel, and regulatory compliance. According to a study published in the 'Pharmaceuticals' journal, the high production costs and additional packaging needs are market restraints for the effervescent tablet industry. Nevertheless, the growing trend towards precise ingredient control and the overall health benefits associated with vitamins and minerals make effervescent tablets an attractive option for consumers. Despite the challenges, the market for effervescent tablets, including those for dietary supplements, is expected to grow due to their unique benefits and the increasing demand for convenient and effective health solutions.
According to Technavio, the global effervescent tablet market is a segment of the expansive global pharmaceuticals industry, encompassing entities involved in R&D and manufacturing of various pharmaceutical products, including generic and non-generic drugs, veterinary medicines, and biotechnology solutions. The size of the global healthcare industry, which includes the pharmaceuticals sector, is determined by Technavio based on the consolidated revenue generated from the sales of medical equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. The growth of the global pharmaceuticals market is anticipated to be driven by several key factors, including the increasing elderly population, whose numbers are projected to rise significantly.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
